The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial

Özmen, V.Özbaş, S.Karanlık, H.Müslümanoğlu, M.Iğcı, A.Cantürk, Z.Utkan, Z.2024-09-252024-09-2520190923-75341569-8041https://hdl.handle.net/20.500.12491/1414844th Congress of the European-Society-for-Medical-Oncology (ESMO) -- SEP 27-OCT 01, 2019 - Barcelona, SPAINThe MF07-01 trial is a multicenter randomized study comparing locoregional treatment (LRT) followed by systemic therapy (ST) with ST alone in de novo stage IV breast cancer (BC) patients. The aim of this study is to evaluate the importance of LRT in patients who lived at least 5 years after the diagnosis of de novo Stage IV BCeninfo:eu-repo/semantics/closedAccessThe importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trialConference Object30WOS:000491295501127Q1